186 related articles for article (PubMed ID: 33436504)
1. Diagnostic role of CXCL13 and CSF serology in patients with neurosyphilis.
Li D; Huang X; Shi M; Luo L; Tao C
Sex Transm Infect; 2021 Nov; 97(7):485-489. PubMed ID: 33436504
[TBL] [Abstract][Full Text] [Related]
2. Value of CXCL13 in diagnosing asymptomatic neurosyphilis in HIV-infected patients.
Hu R; Lu C; Lu S; Hu Y; Ma H; Lai W; Zhu G; Feng P; Lu R; Li Y
Int J STD AIDS; 2016 Feb; 27(2):141-6. PubMed ID: 25769888
[TBL] [Abstract][Full Text] [Related]
3. CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients.
Wang C; Wu K; Yu Q; Zhang S; Gao Z; Liu Y; Ni L; Cheng Y; Guan Z; Shi M; Lu H; Lou Y; Zhou P
Sci Rep; 2016 Sep; 6():33569. PubMed ID: 27650493
[TBL] [Abstract][Full Text] [Related]
4. CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis.
Marra CM; Tantalo LC; Sahi SK; Maxwell CL; Lukehart SA
Sex Transm Dis; 2010 May; 37(5):283-7. PubMed ID: 20393380
[TBL] [Abstract][Full Text] [Related]
5. Has CXCL13 an added value in diagnosis of neurosyphilis?
Mothapo KM; Verbeek MM; van der Velden LB; Ang CW; Koopmans PP; van der Ven A; Stelma F
J Clin Microbiol; 2015 May; 53(5):1693-6. PubMed ID: 25788544
[TBL] [Abstract][Full Text] [Related]
6. CXCL13 and TH1/Th2 cytokines in the serum and cerebrospinal fluid of neurosyphilis patients.
Yan Y; Wang J; Qu B; Zhang Y; Wei Y; Liu H; Wu C
Medicine (Baltimore); 2017 Nov; 96(47):e8850. PubMed ID: 29381995
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal Synthesis Index of Specific Anti-
Alberto C; Deffert C; Lambeng N; Breville G; Gayet-Ageron A; Lalive P; Toutous Trellu L; Fontao L
Microbiol Spectr; 2022 Feb; 10(1):e0147721. PubMed ID: 35138118
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid CXCL13 concentration for diagnosis of neurosyphilis: a systematic review and meta-analysis.
Du FZ; Zhang X; Zheng XL; Zhang RL; Wang QQ
BMJ Open; 2024 May; 14(5):e078527. PubMed ID: 38821573
[TBL] [Abstract][Full Text] [Related]
9. Multicentric evaluation of a specific intrathecal anti-
Alberto C; Lambeng N; Deffert C; Breville G; Gayet-Ageron A; Lalive P; Calmy A; Coste A; Papadimitriou-Olivgeris M; Braun D; Lienhard R; Bosshard PP; Fontao L; Toutous Trellu L
Sex Transm Infect; 2024 Feb; 100(2):63-69. PubMed ID: 38071543
[TBL] [Abstract][Full Text] [Related]
10. Chemokine Ligand 13 (CXCL13) in Neuroborreliosis and Neurosyphilis as Selected Spirochetal Neurological Diseases: A Review of Its Diagnostic Significance.
Gudowska-Sawczuk M; Mroczko B
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331231
[TBL] [Abstract][Full Text] [Related]
11. Clinical prediction and diagnosis of neurosyphilis in HIV-negative patients: a case-control study.
Lu Y; Ke W; Yang L; Wang Z; Lv P; Gu J; Hao C; Li J; Cai Y; Gu M; Liu H; Chen W; Zhang X; Wang L; Liu Y; Yang B; Zou H; Zheng H
BMC Infect Dis; 2019 Dec; 19(1):1017. PubMed ID: 31791265
[TBL] [Abstract][Full Text] [Related]
12. Aberrant Humoral Immune Responses in Neurosyphilis: CXCL13/CXCR5 Play a Pivotal Role for B-Cell Recruitment to the Cerebrospinal Fluid.
Yu Q; Cheng Y; Wang Y; Wang C; Lu H; Guan Z; Huang J; Gong W; Shi M; Ni L; Wu J; Peng R; Zhou P
J Infect Dis; 2017 Sep; 216(5):534-544. PubMed ID: 28931218
[TBL] [Abstract][Full Text] [Related]
13. Alternatives to the Cerebrospinal Fluid Venereal Disease Research Laboratory Test for Neurosyphilis Diagnosis.
Marra CM
Sex Transm Dis; 2021 Aug; 48(8S):S54-S57. PubMed ID: 33967236
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal Fluid Treponema pallidum Particle Agglutination Assay for Neurosyphilis Diagnosis.
Marra CM; Maxwell CL; Dunaway SB; Sahi SK; Tantalo LC
J Clin Microbiol; 2017 Jun; 55(6):1865-1870. PubMed ID: 28381602
[TBL] [Abstract][Full Text] [Related]
15. Biological false-positive venereal disease research laboratory test in cerebrospinal fluid in the diagnosis of neurosyphilis - a case-control study.
Zheng S; Lin RJ; Chan YH; Ngan CCL
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):474-481. PubMed ID: 29117430
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid CXCL13 concentration for diagnosis and monitoring of neurosyphilis in people with HIV.
Carvalho RS; Rangel IC; Soane MM; Bacarov NBS; Herbst V; Ferry FRA
AIDS; 2024 Apr; 38(5):657-668. PubMed ID: 38079581
[TBL] [Abstract][Full Text] [Related]
17. A comparison of nontreponemal tests in cerebrospinal fluid for neurosyphilis diagnosis: equivalent detection of specific antibodies.
Versiani I; Cabral-Castro MJ; Puccioni-Sohler M
Arq Neuropsiquiatr; 2019 Feb; 77(2):91-95. PubMed ID: 30810592
[TBL] [Abstract][Full Text] [Related]
18. Screening for syphilis and neurosyphilis in acute psychiatric admissions.
Roberts MC; Emsley RA; Jordaan GP
S Afr Med J; 1992 Jul; 82(1):16-8. PubMed ID: 1641712
[TBL] [Abstract][Full Text] [Related]
19. Significance of laboratory findings for the diagnosis of neurosyphilis.
Luger AF; Schmidt BL; Kaulich M
Int J STD AIDS; 2000 Apr; 11(4):224-34. PubMed ID: 10772085
[TBL] [Abstract][Full Text] [Related]
20. The rapid plasma reagin test cannot replace the venereal disease research laboratory test for neurosyphilis diagnosis.
Marra CM; Tantalo LC; Maxwell CL; Ho EL; Sahi SK; Jones T
Sex Transm Dis; 2012 Jun; 39(6):453-7. PubMed ID: 22592831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
